Shares of DocGo Inc. (NASDAQ:DCGO – Get Free Report) have received a consensus recommendation of “Hold” from the six analysts that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $2.3750.
A number of equities research analysts recently issued reports on the stock. Canaccord Genuity Group reissued a “hold” rating and issued a $1.00 price target on shares of DocGo in a research note on Tuesday, August 18th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a report on Thursday, June 18th. Wall Street Zen raised shares of DocGo from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Needham & Company LLC reiterated a “buy” rating and issued a $3.00 target price on shares of DocGo in a research report on Tuesday, August 18th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of DocGo in a research note on Monday, May 11th.
Get Our Latest Research Report on DocGo
Institutional Investors Weigh In On DocGo
DocGo Trading Down 4.2%
Shares of DCGO stock opened at $0.38 on Tuesday. DocGo has a twelve month low of $0.35 and a twelve month high of $1.65. The stock has a market cap of $37.69 million, a P/E ratio of -0.19 and a beta of 0.99. The stock has a 50 day moving average of $0.57 and a 200 day moving average of $0.61.
DocGo (NASDAQ:DCGO – Get Free Report) last issued its quarterly earnings data on Monday, August 17th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). The firm had revenue of $73.42 million during the quarter, compared to analyst estimates of $75.35 million. DocGo had a negative return on equity of 40.42% and a negative net margin of 65.29%. On average, research analysts predict that DocGo will post -0.22 earnings per share for the current fiscal year.
About DocGo
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Featured Stories
- Five stocks we like better than DocGo
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
